Pfizer Bivalent Vaccine Reduces COVID-19-Related Death Risk by 68% in Older People: Study
Hospitalisation due to COVID-19 occurred in 32 participants who received a bivalent mRNA booster vaccination and 541 who did not receive a bivalent booster vaccination. Analysis showed this to mean a 72 per cent reduction in hospitalisation risk in those receiving the bivalent booster. �� Pfizer Bivalent Vaccine Reduces COVID-19-Related Death Risk by 68% in Older People: Study.